Preferences for WeChat-Based and Hospital-Based Family Intervention Among Caregivers of People Living with Schizophrenia.
WeChat
caregiving
preference
schizophrenia
Journal
Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
11
2021
accepted:
21
02
2022
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
This study examines the preferences for WeChat-based and hospital-based family intervention among caregivers of people living with schizophrenia (PLS) and identify correlates associated with these preferences. A cross-sectional study was conducted with 449 family caregivers of PLS. Face-to-face interviews were conducted to collect information on socio-demographics, preferences for WeChat-based and hospital-based family intervention, social support, and coping. Over 72.16% of participants endorsed hospital-based family intervention, while 50.11% endorsed WeChat-based family intervention. Endorsement of WeChat-based family intervention was associated with younger age (OR=0.42, 95% CI: 0.22, 0.79), WeChat use (OR=12.90, 95% CI: 7.48, 22.23), and higher social support (OR=1.03, 95% CI: 1.01, 1.04). Endorsement of hospital-based family intervention was associated with lower education (OR=0.19-0.37, 95% CI: 0.07, 0.66) and WeChat use (OR=3.27, 95% CI: 1.91, 5.59). The studies showed a higher endorsement rate for hospital-based family intervention than WeChat-based family intervention and provide implications for developing targeted family intervention programs based on participants' own unique characteristics.
Identifiants
pubmed: 35283626
doi: 10.2147/PPA.S338936
pii: 338936
pmc: PMC8906870
doi:
Types de publication
Journal Article
Langues
eng
Pagination
635-645Informations de copyright
© 2022 Zhang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
JMIR Res Protoc. 2020 Aug 25;9(8):e18538
pubmed: 32687478
Am J Psychiatry. 2001 Feb;158(2):163-75
pubmed: 11156795
Int J Nurs Stud. 2013 Oct;50(10):1326-40
pubmed: 23433723
Lancet Infect Dis. 2015 Jul;15(7):762-3
pubmed: 26122441
BMC Fam Pract. 2011 Apr 16;12:20
pubmed: 21496309
Epidemiol Psychiatr Sci. 2016 Apr;25(2):113-22
pubmed: 26744309
J Consult Clin Psychol. 2018 Jun;86(6):493-504
pubmed: 29781648
JMIR Ment Health. 2020 Apr 3;7(4):e16460
pubmed: 32243256
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD002831
pubmed: 21678337
Psychiatr Serv. 1996 Aug;47(8):825-31
pubmed: 8837153
Rev Saude Publica. 2018 Apr 09;52:37
pubmed: 29641661
J Med Internet Res. 2008 Nov 17;10(4):e42
pubmed: 19017584
Behav Modif. 2015 Nov;39(6):785-804
pubmed: 26187164
BMC Health Serv Res. 2017 Jan 3;17(1):3
pubmed: 28049480
PLoS One. 2018 Feb 26;13(2):e0192119
pubmed: 29481556
Am J Community Psychol. 2008 Sep;42(1-2):122-34
pubmed: 18584319
Aust N Z J Psychiatry. 2001 Oct;35(5):619-25
pubmed: 11551277
Schizophr Bull. 2006 Jul;32(3):432-42
pubmed: 16461575
PLoS One. 2018 Aug 28;13(8):e0202326
pubmed: 30153253
Pharmacoeconomics. 2008;26(2):149-62
pubmed: 18198934
BMC Psychiatry. 2017 Feb 13;17(1):68
pubmed: 28193197
Early Interv Psychiatry. 2018 Aug;12(4):535-560
pubmed: 29076263
Br J Psychiatry. 2015 Apr;206(4):268-74
pubmed: 25833867
JMIR Mhealth Uhealth. 2015 Nov 06;3(4):e102
pubmed: 26546039
J Med Internet Res. 2016 Apr 22;18(4):e92
pubmed: 27105939
Curr Opin Psychiatry. 2005 Mar;18(2):159-63
pubmed: 16639169
Lancet. 2014 May 10;383(9929):1677-1687
pubmed: 24315522
Psychol Med. 2020 Jan;50(1):20-28
pubmed: 30606273
Am J Psychiatry. 2004 Feb;161(2 Suppl):1-56
pubmed: 15000267
Int J Soc Psychiatry. 2013 Jun;59(4):391-7
pubmed: 22433244
Cochrane Database Syst Rev. 2010 Dec 08;(12):CD000088
pubmed: 21154340